They plan to finish this 2nd phase III analyze by the tip of this year. When the phase III is total, MAPS will make an application for FDA approval for MDMA therapy. They foresee FDA approval to come in late 2023. The moment it's approved, the DEA will have a https://droguerieviral.com/product-tag/acheter-de-lamphetamine-liquide/